Jones Financial Companies
CORT icon

Jones Financial Companies’s Corcept Therapeutics CORT Stock Holding History

Jones Financial Companies’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
23,964
+16,405
+217% +$991K ﹤0.01% 1558
2026
Q1 		$284K Buy
7,559
+6,321
+511% +$236K ﹤0.01% 2266
2025
Q4 		$43.1K Buy
1,238
+69
+6% +$5.42K ﹤0.01% 2596
2025
Q3 		$98K Buy
1,169
+549
+89% +$39.7K ﹤0.01% 2100
2025
Q2 		$45.4K Buy
620
+66
+12% +$4.79K ﹤0.01% 2259
2025
Q1 		$30.3K Buy
554
+422
+320% +$25.7K ﹤0.01% 2266
2024
Q4 		$6.65K Hold
132
– – ﹤0.01% 2673
2024
Q3 		$5.8K Sell
132
-169
-56% -$6K ﹤0.01% 2406
2024
Q2 		$9.78K Buy
+301
New +$8.24K ﹤0.01% 1761

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's CORT Position: Q2 2026 in Review

Jones Financial Companies increased its Corcept Therapeutics (CORT) stake by 217% in Q2 2026, buying an estimated $991K and bringing the position to 23,964 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1558.

Jones Financial Companies first reported a position in CORT in Q2 2024 and has held it in 9 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Jones Financial Companies held 23,964 shares of Corcept Therapeutics worth $2.09M as of Q2 2026.
  • Jones Financial Companies bought 16,405 Corcept Therapeutics shares in Q2 2026, an estimated $991K.
  • Corcept Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1558 holding.
  • Jones Financial Companies first reported a position in Corcept Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.